Relationship between antioxidant supplements with melatonin alone and Bavytamyn C on clinical periodontal index of treatment phase.
Conditions
Interventions
Intervention 1: Control chart completion, scaling and brushing by handheld devices, ultrasonic and Rabrkp and paste pumice, administered placebo for 30 days. Intervention 2: Group 2 (intervention), ch
Placebo
Treatment - Drugs
Control chart completion, scaling and brushing by handheld devices, ultrasonic and Rabrkp and paste pumice, administered placebo for 30 days.
Group 2 (intervention), chart completion, scaling and brushing by handheld devices, ultrasonic and Rabrkp and paste pumice, administration of melatonin tablets 2 mg, once a day, for 30 days
Group 3 (intervention), chart completion, scaling and brushing by handheld devices, ultrasonic and Rabrkp and pumice paste, oral administration of melatonin 2 mg, once a day, for 30 days and 60 mg vit
Sponsors
Tabriz University of Medical Sciences, School of Dentistry, Tabriz, gum disease and tooth Research C
Eligibility
Sex/Gender
All
Age
20 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients older than 20 years old with will be enrolled with the following criteria : 1.Patients with Moderate periodotitis; 2.Patients must have teeth excluding third molars in function 3. The absence of systemic disease 4. Full mouth score plaque above 25%; 5 .Non- use of antibiotics in the last three months 6.Willingness to participate in the study.Exclusions criteria of the study are as follow: 1. Pregnancy and lactation; 2. Systemic disease; 3.Of any kind of drugs , tabaco, alcohol; 4.Failure to establish any of the terms of inclusion
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical attachment level (CAL). Timepoint: Befoer the experiment (Baseline) , 3 months after the intervention, 6 month after the intervention. Method of measurement: Measured the distance between the bottom of the stent sulcus by periodontal probe. | — |
Secondary
| Measure | Time frame |
|---|---|
| Plaque. Timepoint: Before the experiment , (Baseline) , 3 months after the intervention, 6 months afte ther intervention. Method of measurement: Disclosing agent by visual scale.;Bleeding on probing (BOP). Timepoint: Before the experiment (Baseline) , 3 months afterthe intervention, 6 months afterintervention. Method of measurement: Bleedingfor 15 seconds afte rgentle probing by periodontal probe.;Probing depth (PD). Timepoint: Before the experiment, three months after the intervention, six months after the intervention. Method of measurement: The distance between the bottom of the sulcus by marginal mucosa and periodontal probe in mm. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mohammad Taghi Chitsazi
Gum disease and tooth Research Center, School of Dentistry, Tabriz
Outcome results
None listed